Prediction Case File
YouTubeTracking Live

Netflix Stock Is Getting Too Cheap To Ignore!

1 extracted signal · 0 resolved · 1 still active

The Patient Investor profile imageThe Patient InvestorIndependent analyst profile
Source published
21 Oct 2026, 15:41 UTC
Recorded by Tahlil Plus
21 Oct 2026, 16:06 UTC
Video preview for Netflix Stock Is Getting Too Cheap To Ignore!
Source overview

AI-generated source summary

Netflix has reported earnings that beat estimates, with revenue matching projections. However, the company has lowered its full-year revenue forecast for 2026 to $51.1 billion, down from a previous estimate of $51.4 billion, and also reduced its ad revenue forecast to $2.7 billion from $3 billion. This guidance reduction is attributed to a slower-than-expected rollout of ad product capabilities. Furthermore, Netflix has increased its subscription prices across all tiers, with the standard plan now at $19.99 and the premium plan at $26.99. Despite these price hikes, the company is facing increased competition from platforms like YouTube, which is gaining market share. Netflix's P/E ratio has fallen to 18, and the speaker suggests a target P/E of 20, implying a potential upside. The stock is trading at a P/E of 18, while the projected forward P/E is around 15.4. The analysis suggests that if Netflix can achieve a P/E of 20 with its projected earnings growth, the stock could reach $133.11, representing a potential upside of 105%. However, the current trend is bearish, with significant price drops observed.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Tracking Live
Signals
1
Extracted from this source
Open
1
Still being tracked
Successful
0
Resolved successfully
Failed
0
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
—
0 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  5. Source processing completed

    Source analysis and structured extraction completed.

  6. Live evaluation in progress

    1 signal remains active.

Analyst snapshot

The Patient Investor

Platform-wide history, separate from this source evaluation.

Reliability
47.9
Tracked signals
359
Historical success
34.9%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail